The diet-microbiota-inflammation axis and colorectal cancer - Report - MDSpire

The diet-microbiota-inflammation axis and colorectal cancer

  • By

  • Konstantinos Kossenas

  • Christos Damaskos

  • Nikolaos Garmpis

  • July 15, 2026

Share

Clinical Report: The Relationship Between Diet, Gut Microbiota, Inflammation, and Colorectal Cancer

Background

Colorectal cancer remains a leading cause of cancer morbidity and mortality globally, necessitating a deeper understanding of its risk factors. Recent studies suggest that dietary patterns and gut microbiota significantly influence CRC risk through mechanisms involving inflammation and microbial metabolites.

Data Highlights

No specific numerical data provided in the source material.

Key Findings

  • Dietary patterns rich in fiber and short-chain fatty acids are associated with a reduced risk of CRC.
  • Western dietary patterns and ultra-processed foods are linked to a pro-inflammatory environment associated with carcinogenesis.
  • Specific microorganisms, such as Fusobacterium nucleatum, have been associated with CRC through inflammatory and immune-modulatory mechanisms.
  • Microbiome-based biomarkers have potential diagnostic and prognostic value in CRC.
  • Microbiota-targeted interventions, including probiotics and fecal microbiota transplantation, have shown early results in clinical studies.

Clinical Implications

Healthcare professionals should consider dietary counseling as part of CRC prevention strategies. Additionally, the exploration of microbiome-targeted therapies may offer new avenues for personalized management of CRC.

Conclusion

The interplay between diet, gut microbiota, and inflammation is important in understanding colorectal carcinogenesis.

Related Resources & Content

  1. Frontiers in Oncology, 2026 -- The gut microbiota in colorectal cancer: role in cytokine regulation, intestinal immune barrier dysfunction
  2. conexiant, 2026 -- Diet-Microbiome Links Drive IBD Inflammation
  3. Frontiers in Immunology, 2026 -- Multidimensional exploration of the relationship between gut microbiota and colorectal cancer: focus on clinical tumorigenesis and treatment
  4. The ASCO Post, 2014 -- Decreased Diversity of Gut Bacteria Associated With Risk of Colorectal Cancer
  5. World Cancer Research Fund -- Our Cancer Prevention Recommendations as a package of behaviours
  6. Nature Microbiology, 2026 -- Decoding microbe–diet–host synergy in colorectal cancer
  7. Our Cancer Prevention Recommendations as a package of behaviours | World Cancer Research Fund
  8. Decoding microbe–diet–host synergy in colorectal cancer | Nature Microbiology
  9. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial - PMC

Original Source(s)

Related Content